The imbalance of Cu + and Cu 2+ in the brain is closely related to neurodegenerative diseases. However, it still lacks of effective analytical methods for simultaneously determining the concentrations of Cu + and Cu 2+ . Herein, we created a novel SERS probe (CuSP) to real‐time track and accurately quantify extracellular concentrations of Cu + and Cu 2+ in the live brain. The present CuSP probe demonstrated specific ability for recognition of Cu + and Cu 2+ in a dual‐recognition mode. Then, a microarray consisting of 8 CuSP probes with high tempo‐spatial resolution and good accuracy was constructed for tracking and simultaneously biosensing of Cu + and Cu 2+ in the cerebral cortex of living brain. Using our powerful tool, it was found that that the concentrations of Cu 2+ and Cu + were increased by ≈4.26 and ≈1.80 times upon ischemia, respectively. Three routes were first discovered for understanding the mechanisms of the increased concentrations of Cu + and Cu 2+ during ischemia.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: